Ocular Hypotensive Efficacy of a New Liposomal Latanoprost Formulation Administered by Different Routes for Experimental Ocular Hypertension. Ukr. j. ophthalmol. 2025, No. 2, 37-41. https://doi.org/10.31288/oftalmolzh202223741.